POSB243 Oncologists’ Preferences for First-Line (1L) Treatment of Locally Advanced/Unresectable or Metastatic Urothelial Carcinoma (aUC)

Abstract

Authors

P Grivas V Phani K Chiu V Pawar J Chang M Bharmal

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×